comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 13:09:40 - browse：634

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Average age of first period drops to 11.9 years, study shows

Wikipedia

explore

WSS

Scientists successfully use ultrasound imaging to map brain activity

Stigma and the return of syphilis

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

David Sabatini, ex

Biohaven protein

Insmed lung disease drug hits target in key Phase 3 trial

entertainment

comprehensive

hotspot

Psychedelics group wrestles with new pharma identity

Cano Health’s bankruptcy is a warning for Medicare Advantage

Walensky prepares to leave CDC — and Congress — behind

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Cancer drug shortages should be causing more outrage

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Malaria cases in Florida and Texas: Here’s what you need to know

The CDC's new social media misinformation war

Psychedelics group wrestles with new pharma identity

Problems with a popular proposal to regulate AI in health care

Wikipedia

A single Democrat is willing to weaken Medicare negotiation power

Insmed lung disease drug hits target in key Phase 3 trial

AstraZeneca stays mum on Medicare drug pricing negotiations

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

What’s missing from the debate over nursing home staff minimums

Wikipedia

explore

Wikipedia

hotspot